Investors

Novartis (NYSE: NVS), which was created in 1996 by the merger of the Swiss companies Ciba-Geigy and Sandoz, is a world leader in the research and development of products that protect and improve health and well-being. Its core businesses are in pharmaceuticals, vaccines, consumer health, generics, eye care, and animal health.

Visit the Novartis Investors relations section